With 1.16 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.3 million shares. The 52-week range on CYRX shows that it touched its highest point at $20.10 and its lowest point at $4.58 during that stretch. It currently has a 1-year price target of $11.21. Beta for the stock currently stands at 1.94.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CYRX was up-trending over the past week, with a rise of 11.09%, but this was down by -10.43% over a month. Three-month performance dropped to -6.64% while six-month performance fell -29.08%. The stock lost -63.09% in the past year, while it has lost -15.04% so far this year. A look at the trailing 12-month EPS for CYRX yields -3.39 with Next year EPS estimates of -0.97. For the next quarter, that number is -0.32. This implies an EPS growth rate of 55.58% for this year and 12.14% for next year. EPS is expected to grow by 31.37% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -45.48%.
Float and Shares Shorts:
At present, 49.43 million CYRX shares are outstanding with a float of 47.66 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CYRX since 4 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.13211 being high and -$2.56332 being low. For CYRX, this leads to a yearly average estimate of -$2.37167. Based on analyst estimates, the high estimate for the next quarter is -$0.21 and the low estimate is -$0.31. The average estimate for the next quarter is thus -$0.25.
Summary of Insider Activity:
Insiders traded CYRX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
